HBIO
Harvard Bioscience, Inc.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$8.02
+0.25%Leverage
- Debt / equity
- 5.96x
- Net debt / equity
- 5.08x
- Debt / assets
- 0.58x
- Debt / EBITDA
- -47.08x
- Net debt / EBITDA
- -40.15x
Liquidity & coverage
- Current ratio
- 1.87x
- Quick ratio
- 0.98x
- Cash ratio
- 0.26x
- Interest coverage
- 0.30x
- EBITDA / interest
- -0.28x
- Working capital
- $21.7M
Cash & dividend
- FCF / debt
- -0.03x
- Cash flow / debt
- 0.01x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026